About us

Carlo is a chemical engineer with long experience in the field of production and quality assurance in manufacturing of AAV virus, injectable liquids (Vaccines) in Aseptic Operations, and of APIs for pharmaceutical and food applications produced by fermentation and/or synthetic pathway in CDMO organizations.

During his professional experience he has held several roles in multinational companies, mainly in the field of Quality & Sterility Assurance, Production Management and implementation of new products from the development to production on an industrial scale.

In 2023 Carlo joined InnovAAVector s.r.l. leading the GMP manufacturing unit.

Rosanna held MSc degree in Medical and Pharmaceutical Biotechnology at Università degli studi di Firenze in 2016 and has been active in the advanced therapy field since 2018.

She gained QC and QA experience for three years in AGC Biologics.
Rosanna joined InnovAAVector s.r.l. in September 2021 as Manufacturing specialist, actively participating in the production of the first AAV validation Batch.

In 2023 joined the QA unit as specialist and in March 2025 as manager.

Named as Qualified person in accordance with D.L.vo n. 219/06 and the D.L.vo n.269/03 and their modifications.

Monica Doria has extensive experience in the field of genetic research and extensive technical know-how in the production of viral vectors that has lasted for over twenty years. She currently works as research grade AAV production manager at InnovAAVector s.r.l. since 2020.

Previously, from 2002 to 2020, she managed the AAV Vector Core Facility of TIGEM (Telethon Institute of Genetics and Medicine, Pozzuoli, Italy) and developed a production and purification process that allowed the production of thousands of batches of AAV vectors for use in preclinical studies. Previously, after graduating at Federico II University of Naples, she dedicated herself to scientific research studying molecular mechanisms of the action of hormones on neoplastic cells, at the Vanvitelli University of Naples.

Master Degree in Biological Sciences and Ph.D in Medical Genetics and has been active in the advanced therapy field since 2004. Senior Researcher with 8-year research experience in Gene Therapy studies with AAV vectors. Expert biologist with seven-year GMP experience in Quality department of investigational vaccines for infectious diseases including HCV, malaria, RSV, HIV, Ebola, leishmaniosis, HBV, cancer and Coronavirus (Advent GMP facility/ IRBM Science Park). Joined IV in April 2020 as Quality Unit Manager where currently, after AIFA authorization for Sterile Medicine Production, she moves to support the General Direction as the CMC Project Manager and Qualified Person.

Qualified person for Advanced Therapies: AIFA certification according to “Decreto legislativo 24 aprile 2006 nr. 219 Art. 52”.

Chiara held MSc degree in medical biotechnology at Università degli studi di Napoli Federico II in 2017 and has been active in advanced therapy field since 2016. She gained salient experience for several years in Reithera, at the beginning as R&D grade AAV Vectors development scientist and then as Quality Control specialist.

Chiara joined InnovAAVector s.r.l. in October 2020 as Quality control senior scientist and from 2023 as Quality control manager.

Antonio held MSc degree in Pharmaceutical Biotechnology at Università degli studi di Siena and MBA at Bologna Business School.

Before joining InnovAAVector s.r.l. in 2021, Antonio covered several positions into multinational companies. From Novartis Vaccines & Diagnostic and GlaxoSmithKline where he gained experiences in Supplier Quality, Aseptic Production and Direct Procurement to Philip Morris International where first in Bologna and then in London he had the chance to increase his know-how into the FCMG industry covering roles of increasing responsibility into the SupplyChain and IM&S Procurement.

Rito graduated cum laude in Chemical Engineering at the “Federico II” University of Naples after completing his studies collaborating with Plasmon, Kraft-Heinz group, on the fermentation of engineered bacterial strains and then Rito joined UNILEVER within the Italian Global Research Center in Casalpusterlengo (LO) within the CTI team of Hard Suface Cleaners.

In 2011 Rito held firstly Process Engineer in bacterial area and then Reliability site engineer role for Glaxo, Smith & Kline at the Siena-Rosia site (formerly Novartis Vaccines & Diagnostics), gaining knowledge and responsibilities into the Engineering Dept as Reliability Eng Team Coordinator. During this experience he had the opportunity, among other activities, to participate in several AIFA, FDA and other Authorities Audits for the Engineering Department.

Before joining InnovAAVector s.r.l., Rito held a crucial role in Menarini Farmaceutici (IT) as Corporate Engineering Manager following the realization of a Green Field Pharmaceutical Site for vaccine production, coordinating the construction, commissioning and qualification activities.

Since 2020 Rito is part of the InnovAAVector s.r.l. team as Engineering and Facility Manager, following the construction, start-up, commissioning and qualification activities of the new Gene Therapy facility in the city of Pozzuoli (NA).